Kartos Therapeutics, Inc.

94065 (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£6,144,878

Feb 24 - Feb 29

Engineering the bone marrow niche to control stem cell regulation, metastatic evolution and cancer dormancy

EPSRC award to University of Glasgow and Matthew Dalby

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}